Spinal Tech

The FDA approved Boston Scientific's Spectra WaveWriter Spinal Cord Stimulator System.

The FDA cleared 59 orthopedic devices in December 2017.

Johnson & Johnson CEO Alex Gorsky spoke with CNBC at the J.P. Morgan Health Care Conference discussing tax reforms and the outlook for mergers and acquisitions in the medtech space.

Pompano Beach, Fla.-based medical device manufacturer Stimwave agreed to over $50 million in financing from undisclosed investors for its consumer launch of an opioid-free pain management microchip stimulator.

4WEB Medical saw a 57 percent boost in year-over-year growth in 2017.

Medtronic presented a plan to restructure the company at the J.P. Morgan Healthcare Conference and reported some of the details in a Securities and Exchange Commission filing, according to the Minneapolis/St. Paul Business Journal.

Orthofix released its preliminary 2017 fourth quarter and fiscal year 2017 year-end net sales results.

On Jan. 10, Misonix's president and CEO rang the Nasdaq Stock Market Closing Bell.

Spinal Elements appointed Paul Graveline its new executive vice president and chief commercial officer.

Globus Medical released its preliminary 2017 fourth quarter and full year sales results.